Where does Caris MPI, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Caris MPI, Inc. ranks #20,891 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Caris MPI, Inc. hold?

Caris MPI, Inc. holds 13 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Caris MPI, Inc.'s Innovation Score?

Caris MPI, Inc. has an Innovation Score of 53.7 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Caris MPI, Inc.'s patent grant rate increasing or decreasing?

Caris MPI, Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Caris MPI, Inc.'s patents?

Caris MPI, Inc.'s patents average 22.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Caris MPI, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Caris MPI, Inc.

Q: What technology areas does Caris MPI, Inc. focus on?

Caris MPI, Inc.'s top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 13 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Caris ranks #20,891 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 10 technology areas.

#20,891
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.7/100): 22.3
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20891 · US Corporation #20,891 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,891/49,997
PHOTO-FINISH California Eastern…
CPC-FOCUS G16B · 10 areas
INNOV-PAR 53.7/100
CLAIMS-DENSE 22.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: California Eastern Laboratories, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Caris MPI · this assignee

54
3D Lighting… · lowest

7

What this shows Caris's Innovation Score is 53.7/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Caris's grants concentrate

Caris MPI, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2022. By volume, Caris sits between California Eastern Laboratories, Inc. and Cellresin Technologies, LLC.

Caris's three-year grant acceleration

Caris MPI, Inc. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

California Easter…

13
Canburg

13
Carbon Engineering

13
Careband

13
Caris Science

13
Catbird Networks

13
Cellphire

13
Cellresin

13
Caris MPI ◀

13

What this shows Caris holds 13 patents at rank #20,933, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Caris

By rank, the assignees closest to #20,933 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Caris's primary technology class.

Caris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Caris MPI, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	30.8%
2016	5	38.5%
2022	1	7.7%
2023	1	7.7%
2024	1	7.7%
2025partial year	1	7.7%

Which technologies does Caris MPI, Inc. patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 13

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 11

Y02A - Technologies FOR Adaptation TO Climate Change 10

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 8

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 8

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 8

G06N - Computing Arrangements Based ON Specific Computational Models 3

A61B - DIAGNOSIS; SURGERY; Identification 2

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#20,891

of 49,997 tracked assignees

Innovation Score

53.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Caris MPI, Inc.'s patent record in context - here's where to go next.

Caris MPI, Inc.'s lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 100% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #20,891 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Caris MPI, Inc. against California Eastern Laboratories, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.